France· FR:67288175
AXEPIM 2 g, poudre pour solution injectable
A medicinal product containing céfépime (dichlorhydrate de) monohydraté, registered in France by BRISTOL MYERS SQUIBB.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CÉFÉPIME (DICHLORHYDRATE DE) MONOHYDRATÉ
- Manufacturer
- BRISTOL MYERS SQUIBB
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009370234671 flacon(s) en verre de 3,846 g
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Céfépime (dichlorhydrate de) monohydraté in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsCefepim Fresenius Kabi 2 g, poeder voor oplossing voor injectie of infusieFresenius Kabi Nederland B.V.
- United StatescefepimeSagent Pharmaceuticals
- BelgiumCefepim Fresenius Kabi 1 gFresenius Kabi
- CzechiaCEFEPIM MIPMIP Pharma GmbH, Blieskastel
- SpainCEFEPIMA ACCORD 1 g POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFGAccord Healthcare S.L.U.
- PolandCefepim MIP PharmaMIP Pharma GmbH
- GermanyCefepim AccordAccord Healthcare B.V.
- FinlandCefepim MIP PharmaMIP Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Cefepim Aptapharma, Cefepim Mip
- Belgium · Cefepim Fresenius Kabi, Céfépime Ldp-Laboratorios Torlan
- Bulgaria · Алфацеф, Бактерипим
- Cyprus · Cefepim Noridem, Cefepime Aptapharma
- Czechia · Cefepim Mip, Cefepim Noridem
- Germany · Cefepim Accord, Cefepim Mip
- Denmark · Cefepim Mip
- Estonia · Alphacef, Cefepime Mip
- Spain · Cefepima Kabi, Cefepima Ldp-Laboratorios Torlan
- Finland · Cefepim Mip Pharma
- Greece · Anticepim, Cefepime /Kabi
- Croatia · Cefepim Aptapharma, Cefepime Kabi
- Hungary · Cefepim Aptapharma, Cefepim Noridem
- Italy · Cefepime Noridem, Cefepime Qilu
- Lithuania · Cefepime Mip, Cefepime Norameda
- Luxembourg · Cefepime Noridem
- Latvia · Cefepime Mip, Cefepime Norameda
- Malta · Cefepime Aptapharma
- Netherlands · Cefepim Fresenius Kabi, Cefepim Noridem
- Norway · Cefepim Mip
- Poland · Cefepim Mip Pharma, Cefepime Aptapharma
- Portugal · Cefepima Accord, Cefepima Basi
- Romania · Cefepimă Aptapharma, Cefepimă Mip
- Sweden · Cefepim Mip
- Slovenia · Cefepim Aptapharma, Cefepim Kabi
- Slovakia · Cefepim Mip, Cefepím Noridem
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e7d7fa3a-d537-483c-bfd2-8e32f3c902f5 GET /v1/drugs/e7d7fa3a-d537-483c-bfd2-8e32f3c902f5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67288175",
"date_amm": "1993-07-27",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CÉFÉPIME (DICHLORHYDRATE DE) MONOHYDRATÉ",
"statut_amm": "Autorisation abrogée",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "poudre pour solution injectable",
"voies_administration": "intramusculaire;intraveineuse",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about céfépime (dichlorhydrate de) monohydraté.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.